OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Eradicating HIV-1 infection: seeking to clear a persistent pathogen
Nancie M. Archin, Julia Marsh Sung, Carolina Garrido, et al.
Nature Reviews Microbiology (2014) Vol. 12, Iss. 11, pp. 750-764
Open Access | Times Cited: 268

Showing 1-25 of 268 citing articles:

Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection
Rebecca M. Lynch, Eli Boritz, Emily E. Coates, et al.
Science Translational Medicine (2015) Vol. 7, Iss. 319
Closed Access | Times Cited: 428

Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies
Amanda M. Crooks, Rosalie Bateson, Anna B. Cope, et al.
The Journal of Infectious Diseases (2015) Vol. 212, Iss. 9, pp. 1361-1365
Open Access | Times Cited: 391

Targeting the Latent Reservoir for HIV-1
Srona Sengupta, Robert F. Siliciano
Immunity (2018) Vol. 48, Iss. 5, pp. 872-895
Open Access | Times Cited: 314

Current status and prospects of HIV treatment
Tomás̆ Cihlář, Marshall W. Fordyce
Current Opinion in Virology (2016) Vol. 18, pp. 50-56
Open Access | Times Cited: 302

Human Immunodeficiency Virus (HIV)

Transfusion Medicine and Hemotherapy (2016) Vol. 43, Iss. 3, pp. 203-222
Open Access | Times Cited: 294

Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends
Peng Zhan, Christophe Pannecouque, Erik De Clercq, et al.
Journal of Medicinal Chemistry (2015) Vol. 59, Iss. 7, pp. 2849-2878
Closed Access | Times Cited: 289

Defining HIV and SIV Reservoirs in Lymphoid Tissues
Claire Deléage, Stephen W. Wietgrefe, Gregory Q. Del Prete, et al.
Pathogens and Immunity (2016) Vol. 1, Iss. 1, pp. 68-68
Open Access | Times Cited: 233

Latency reversal and viral clearance to cure HIV-1
David M. Margolis, J. Víctor García, Daria J. Hazuda, et al.
Science (2016) Vol. 353, Iss. 6297
Open Access | Times Cited: 221

HIV persists throughout deep tissues with repopulation from multiple anatomical sources
Antoine Chaillon, Sara Gianella, Simon Dellicour, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 4, pp. 1699-1712
Open Access | Times Cited: 194

Interval dosing with the HDAC inhibitor vorinostat effectively reverses HIV latency
Nancie M. Archin, Jennifer Kirchherr, Julia Sung, et al.
Journal of Clinical Investigation (2017) Vol. 127, Iss. 8, pp. 3126-3135
Open Access | Times Cited: 176

Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs
Liang Cheng, Jianping Ma, Jingyun Li, et al.
Journal of Clinical Investigation (2016) Vol. 127, Iss. 1, pp. 269-279
Open Access | Times Cited: 167

HIV “shock and kill” therapy: In need of revision
Erik Abner, Albert Jordan
Antiviral Research (2019) Vol. 166, pp. 19-34
Closed Access | Times Cited: 142

The Latent Reservoir for HIV-1: How Immunologic Memory and Clonal Expansion Contribute to HIV-1 Persistence
Alexandra J. Murray, Kyungyoon J. Kwon, Donna L. Färber, et al.
The Journal of Immunology (2016) Vol. 197, Iss. 2, pp. 407-417
Open Access | Times Cited: 137

Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection
Line K. Vibholm, Mariane H. Schleimann, Jesper Falkesgaard Højen, et al.
Clinical Infectious Diseases (2017) Vol. 64, Iss. 12, pp. 1686-1695
Open Access | Times Cited: 133

Healing Without Waging War: Beyond Military Metaphors in Medicine and HIV Cure Research
Jing‐Bao Nie, Adam Gilbertson, Malcolm de Roubaix, et al.
The American Journal of Bioethics (2016) Vol. 16, Iss. 10, pp. 3-11
Open Access | Times Cited: 128

HIV-1 Reservoirs During Suppressive Therapy
Kirston Barton, Anni Winckelmann, Sarah Palmer
Trends in Microbiology (2016) Vol. 24, Iss. 5, pp. 345-355
Open Access | Times Cited: 117

Epigenetic control of HIV-1 post integration latency: implications for therapy
Amit Kumar, Gilles Darcis, Carine Van Lint, et al.
Clinical Epigenetics (2015) Vol. 7, Iss. 1
Open Access | Times Cited: 104

Paediatric HIV infection: the potential for cure
Philip Goulder, Sharon R. Lewin, Ellen M. Leitman
Nature reviews. Immunology (2016) Vol. 16, Iss. 4, pp. 259-271
Open Access | Times Cited: 101

CRISPR-mediated Activation of Latent HIV-1 Expression
Prajit Limsirichai, Thomas Gaj, David V. Schaffer
Molecular Therapy (2015) Vol. 24, Iss. 3, pp. 499-507
Open Access | Times Cited: 99

LEDGIN-mediated Inhibition of Integrase–LEDGF/p75 Interaction Reduces Reactivation of Residual Latent HIV
Lenard Vranckx, Jonas Demeulemeester, Suha Saleh, et al.
EBioMedicine (2016) Vol. 8, pp. 248-264
Open Access | Times Cited: 97

Are T cells the only HIV-1 reservoir?
Abraham J. Kandathil, Sho K. Sugawara, Ashwin Balagopal
Retrovirology (2016) Vol. 13, Iss. 1
Open Access | Times Cited: 96

The Interplay of HIV-1 and Macrophages in Viral Persistence
Chynna M. Hendricks, Thaissa Isaias Cordeiro, Ana Paula Neutzling Gomes, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 76

Engaging innate immunity in HIV-1 cure strategies
Nathan L. Board, Milica Moskovljevic, Fengting Wu, et al.
Nature reviews. Immunology (2021) Vol. 22, Iss. 8, pp. 499-512
Open Access | Times Cited: 70

Structure and Dynamics of the Native HIV-1 Env Trimer
James B. Munro, Walther Mothes
Journal of Virology (2015) Vol. 89, Iss. 11, pp. 5752-5755
Open Access | Times Cited: 86

Page 1 - Next Page

Scroll to top